Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022 Aug 18;15(2):e1846. doi: 10.1002/wnan.1846

FIGURE 4.

FIGURE 4

(a) Schematic that shows how DOX-MFPL target S180 tumor in mice B. Pharmacokinetic behavior of different DOX preparations in S180 tumor-bearing mice. The data are expressed as mean ± SD (n = 3). (c) Quantification of the DOX distribution in tumor after i.v. administration of different DOX formulations. (d) AUC of DOX in tumors after intravenous administration of different DOX formulations into the S180-bearing mice at a DOX dosage of 5 mg/kg. **p < 0.01. (e) The S180 tumor stroma volume versus time curve of tumor-bearing mice i.v. injected with various DOX preparation (Li et al., 2019)